Prestige BioPharma Limited (KRX:950210)
South Korea · Delayed Price · Currency is KRW 7,110.00
-280.00 (-3.79%)
At close: May 28, 2026
-50.04% (1Y)
| Market Cap | 85.46B -52.0% |
| Revenue (ttm) | 19.02B +224.2% |
| Net Income | 13.68B |
| EPS | 227.41 |
| Shares Out | 12.02M |
| PE Ratio | 31.26 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 101,123 |
| Open | 7,290.00 |
| Previous Close | 7,390.00 |
| Day's Range | 6,940.00 - 7,500.00 |
| 52-Week Range | 6,940.00 - 20,000.00 |
| Beta | 0.54 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 29, 2026 |